跳至主要内容
临床试验/JPRN-jRCTs072180005
JPRN-jRCTs072180005已完成2 期

Clinical research for efficacy and safety of hand-finger rehabilitation robot SMOVE in the goods operation training for the patients with upper limb paresis after recovery stage stroke patients: A pilot study under single center, open-label, randomized, standard therapy controlled trial. - SMOVE pilot study_02

Kagiyama Tomoko0 个研究点目标入组 16 人开始时间: 2018年10月25日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

o significant difference in recovery of affected hand / upper limb function due to the difference in intervention between the two groups was revealed. No serious side effects due to SMOVE or malfunction of SMOVE during the intervention were observed.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 85age old(—)
性别
All

入选标准

  • Age Between 20 y.o. and 85 y.o.
  • in convalescent stage (15 days to 42 days after onset)
  • with cerebral stroke (cerebral infarction or hemorrhage)
  • being treated with rehabilitation therapy in convalescent stage rehabilitation beds.
  • with hand/finger Brunnstrom stage III to IV

排除标准

  • with subarachnoid hemorrhage
  • having upper limb paresis caused not by cerebral stroke.
  • with severe hepatic / renal /cardiac / pulmonary failure
  • with malignant tumor not completely cured
  • whose skin condition is not suitable for electrodes placement, or device putting on their hands.
  • with severe spasticity ( upper than MAS 3)
  • who are treated with type A botulinus toxin or ITB therapy

研究者

发起方
Kagiyama Tomoko

相似试验